Research Article

Potential Influential Factors of In-Hospital Myocardial Reinfarction in ST-Segment Elevation Myocardial Infarction (STEMI) Patients: Finding from the Improving Care for Cardiovascular Disease in China- (CCC-) Acute Coronary Syndrome (ACS) Project

Table 2

Acute management within 24 hours of admission.

VariablesTotal ()Reinfarction ()Nonreinfarction ()

Fibrinolysis (%) ()3.6 (1350)8.7 (11)3.6 (1339)0.005
PCI (%) ()83.7 (30026)73.7 (84)83.8 (29942)0.005
Reperfusion (%) ()85.2 (34860)80.0 (88)85.2 (29616)0.123
DAPT (%) ()95.0 (37922)90.2 (138)95.0 (37784)0.006
Aspirin (%) ()96.0 (38295)92.2 (141)96.0 (38154)0.017
P2Y12 inhibitor (%) ()96.7 (38591)93.5 (143)96.7 (38448)0.024
Clopidogrel (%) ()76.0 (30337)75.8 (116)76.0 (30211)0.989
Ticagrelor (%) ()26.2 (10436)22.9 (35)26.2 (10401)0.354
β-Blocker (%) ()53.3 (21246)53.6 (82)53.2 (21164)0.932
ACEI/ARB (%) ()46.7 (18636)42.5 (65)46.7 (18571)0.293
Statin (%) ()93.9 (37482)89.5 (137)94.0 (37345)0.022
GP IIb/IIa receptor blockers (%) ()38.9 (15503)35.9 (55)38.9 (15448)0.461
Anticoagulants (%) ()79.3 (31626)78.4 (120)79.3 (31506)0.799